U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07342465) titled 'Gamma Light and Sound Stimulation in Schizophrenia' on Nov. 21, 2025.
Brief Summary: Schizophrenia (SZ) is a severe neuropsychiatric disorder impacting over 20 million people globally, causing significant personal and societal burdens, particularly due to cognitive deficits and negative symptoms inadequately treated by current therapies. To address this gap, investigators propose using Gamma Entrainment Using Sensory Stimulation (GENUS), a novel, home-based treatment involving synchronized 40 Hz light-and-sound stimulation aimed at improving neural synchrony, cognition, and SZ symptoms. This innovative approach leverages advanced ne...